Sustina DS
Rx500 mg/2 ml • আইএম ইনজেকশন
ইঙ্গিত ও ব্যবহার
Hydrogest DS is indicated for-Reducing the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birthPrevention of preterm labor in a singleton pregnancy for patients aged 16 years or older who have a history of spontaneous preterm birth
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
প্রাপ্তবয়স্ক:
Administer intramuscularly at a dose of 500 mg or 250 mg once weekly. Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation. Continue administration once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first.Administration- Clean the ampoule top with an alcohol swab before use. Draw up 1 ml of drug into a 2 ml syringe. After preparing the skin, inject in the upper outer quadrant of the gluteus maximus. The solution is viscous and oily. Slow injection (over one minute or longer) is recommended. Applying pressure to the injection site may minimize bruising and swelling.
পার্শ্বপ্রতিক্রিয়া
Most Common: Injection site reactions (pain, swelling, pruritus, nodule), Hives, Itching, nausea, and diarrhea. Call your doctor if you get any of the symptoms below: Blood clots Symptoms: Leg swelling, Redness in your leg, a spot on your leg that is warm to touch, Leg pain that worsens when you bend your foot. Allergic reactions: Hives, Itching, Swelling of the face.
সতর্কতা ও নিষেধাজ্ঞা
সতর্কতা ও সাবধানতা
Thromboembolic disorders: Discontinue if thrombosis or thromboembolism occurs. Allergic reactions: Consider discontinuing if allergic reactions occur. Decreased glucose tolerance: Monitor pre-diabetic and diabetic women receiving Hydrogest DS. Fluid retention: Monitor women with conditions that may be affected by fluid retention, such as pre-eclampsia, epilepsy, cardiac or renal dysfunction. Depression: Monitor women with a history of clinical depression; discontinue Hydrogest DS if depression recurs. Jaundice: Carefully monitor women who develop jaundice while receiving Hydrogest DS and consider whether the benefit of use warrants continuation. Hypertension: Carefully monitor women who develop hypertension while receiving Hydrogest DS and consider whether the benefit of use warrants continuation.
নিষেধাজ্ঞা
Current or history of thrombosis or thromboembolic disorders. Known or suspected breast cancer, other hormone-sensitive cancer, or history of these conditions. Undiagnosed abnormal vaginal bleeding unrelated to pregnancy. Cholestatic jaundice of pregnancy. Liver tumors, benign or malignant, or active liver disease. Uncontrolled hypertension.